Skip to content

Construction of a Multimodal Central-Peripheral Physiological Signal Dataset for Post-Stroke Patients Based on Non-Invasive Brain-Computer Interface

Construction of a Multimodal Central-Peripheral Physiological Signal Dataset for Post-Stroke Patients Based on Non-Invasive Brain-Computer Interface

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600131692
Enrollment
Unknown
Registered
2026-09-05
Start date
2026-10-01
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After a stroke, 70% to 80% of patients are unable to live independently due to physical disabilities, which greatly impacts their quality of life and imposes a substantial social burden. The recovery of walking function is a crucial goal for achieving independent living.

Interventions

Healthy Control Group:No

Sponsors

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnostic criteria for various cerebrovascular diseases issued by the Chinese Society of Neurology, stroke patients confirmed by head CT or MRI are eligible for inclusion. Each enrolled patient is required to undergo an MRI examination. The inclusion criteria are as follows: 2. disease duration between 2 weeks and 2 years; 3. age 18-80 years; 4. Brunnstrom motor function stage 2-5; 5. Mini-Mental State Examination (MMSE) score > 24, indicating good cognitive status and normal verbal communication or the ability to follow motor commands, with willingness to cooperate; 6. sitting balance grade 2 or above; 7. conscious and alert, with a Glasgow Coma Scale (GCS) score of 15.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of three or more episodes of ischemic or hemorrhagic brain injury; 2. patients with severe clinical comorbidities or complications such as coronary heart disease, angina pectoris, heart failure, atrial fibrillation or other severe arrhythmias, lower limb venous thrombosis, pulmonary embolism, or severe mental disorders; 3. patients with a history of severe motor, balance, cognitive, or speech function impairments; 4. conditions that significantly affect inflammatory indicators, such as severe infections, immunosuppression, use of glucocorticoids, or severe liver and kidney damage; 5. patients with incomplete clinical data; 6. individuals with conditions such as aphasia, visual impairment, or hearing problems, as well as those lost to follow-up; 7. those who have not signed the informed consent form.

Design outcomes

Primary

MeasureTime frame
Facial Action Units;

Secondary

MeasureTime frame
FNIRS;Berg Balance Scale;Fatigue Severity Scale;A Super;EEG;National Institutes of Health Stroke Scale;Fugl-Meyer motor function;FMRI;SEMG;EAD;Brunnstrom;NRS;Montreal Cognitive Assessment;NIHSS;HADS;SF-12;

Countries

China

Contacts

Public ContactWu Ming

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

ahslyywm@163.com+86 551 62284091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026